Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans
The kinetics of apolipoproteins A-I and A-II were examined in human subjects using leucine tracers administered intravenously. High density lipoproteins were separated and apoA-I and A-II were isolated. The specific activity or enrichment data for these apolipoprotein were analyzed by mathematical c...
Saved in:
Published in | Journal of lipid research Vol. 36; no. 7; pp. 1618 - 1628 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier
01.07.1995
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The kinetics of apolipoproteins A-I and A-II were examined in human subjects using leucine tracers administered intravenously. High density lipoproteins were separated and apoA-I and A-II were isolated. The specific activity or enrichment data for these apolipoprotein were analyzed by mathematical compartmental modeling. In 11 of 14 subjects studied with a bolus-injected [3H]leucine tracer, in 3 subjects studied similarly with [3H]leucine, and in one subject studied by primed dose, constant infusion of [3H]leucine, a rapidly turning-over apoA-I fraction was resolved. A similar component was observed in 7 of 10 studies of apoA-II. The apoA-I data were analyzed using a compartmental model (Zech, L.A. et al. 1983. J. Lipid Res. 24: 60-71) modified to incorporate plasma leucine as a precursor for apoprotein synthesis. The data permitted resolution of two apoA-I pools, one, C(2), turned-over with a residence time of less than 1 day, the other, C(1), a slowly turning-over pool, appeared in plasma after a delay of less than half a day. C(1) comprised the predominant mass of apoA-I and was also the primary determinant of the residence time of apoA-I. Although the mass of the fast pool, C(2), was considerably less than that of C(1), because of its rapid turnover, the quantities of apoA-I transported through this fast pathway were 2- to 4-fold greater. These kinetic studies indicate that apoA-I is secreted into both fast and slowly turning-over plasma pools. The latter is predominantly measured with radioiodinated apoA-I tracers. The data can be analyzed by postulating either separate input pathways to each of the pools or by assuming the fast pool is the precursor to the slow pool. Thus, apoA-I could be initially secreted as a family of particles that are rapidly cleared from plasma, and a portion of this apoprotein then reappears in a slowly turning-over pool that constitutes the major mass of apoA-I. The physiologic identity of these kinetically distinct apoA-I species is unknown; however, the fast pool of apoA-I demonstrated in these studies is strikingly similar to that seen in subjects with Tangier disease who lack the slow pool. |
---|---|
AbstractList | The kinetics of apolipoproteins A-I and A-II were examined in human subjects using leucine tracers administered intravenously. High density lipoproteins were separated and apoA-I and A-II were isolated. The specific activity or enrichment data for these apolipoprotein were analyzed by mathematical compartmental modeling. In 11 of 14 subjects studied with a bolus-injected [3H]leucine tracer, in 3 subjects studied similarly with [3H]leucine, and in one subject studied by primed dose, constant infusion of [3H]leucine, a rapidly turning-over apoA-I fraction was resolved. A similar component was observed in 7 of 10 studies of apoA-II. The apoA-I data were analyzed using a compartmental model (Zech, L.A. et al. 1983. J. Lipid Res. 24: 60-71) modified to incorporate plasma leucine as a precursor for apoprotein synthesis. The data permitted resolution of two apoA-I pools, one, C(2), turned-over with a residence time of less than 1 day, the other, C(1), a slowly turning-over pool, appeared in plasma after a delay of less than half a day. C(1) comprised the predominant mass of apoA-I and was also the primary determinant of the residence time of apoA-I. Although the mass of the fast pool, C(2), was considerably less than that of C(1), because of its rapid turnover, the quantities of apoA-I transported through this fast pathway were 2- to 4-fold greater. These kinetic studies indicate that apoA-I is secreted into both fast and slowly turning-over plasma pools. The latter is predominantly measured with radioiodinated apoA-I tracers. The data can be analyzed by postulating either separate input pathways to each of the pools or by assuming the fast pool is the precursor to the slow pool. Thus, apoA-I could be initially secreted as a family of particles that are rapidly cleared from plasma, and a portion of this apoprotein then reappears in a slowly turning-over pool that constitutes the major mass of apoA-I. The physiologic identity of these kinetically distinct apoA-I species is unknown; however, the fast pool of apoA-I demonstrated in these studies is strikingly similar to that seen in subjects with Tangier disease who lack the slow pool.The kinetics of apolipoproteins A-I and A-II were examined in human subjects using leucine tracers administered intravenously. High density lipoproteins were separated and apoA-I and A-II were isolated. The specific activity or enrichment data for these apolipoprotein were analyzed by mathematical compartmental modeling. In 11 of 14 subjects studied with a bolus-injected [3H]leucine tracer, in 3 subjects studied similarly with [3H]leucine, and in one subject studied by primed dose, constant infusion of [3H]leucine, a rapidly turning-over apoA-I fraction was resolved. A similar component was observed in 7 of 10 studies of apoA-II. The apoA-I data were analyzed using a compartmental model (Zech, L.A. et al. 1983. J. Lipid Res. 24: 60-71) modified to incorporate plasma leucine as a precursor for apoprotein synthesis. The data permitted resolution of two apoA-I pools, one, C(2), turned-over with a residence time of less than 1 day, the other, C(1), a slowly turning-over pool, appeared in plasma after a delay of less than half a day. C(1) comprised the predominant mass of apoA-I and was also the primary determinant of the residence time of apoA-I. Although the mass of the fast pool, C(2), was considerably less than that of C(1), because of its rapid turnover, the quantities of apoA-I transported through this fast pathway were 2- to 4-fold greater. These kinetic studies indicate that apoA-I is secreted into both fast and slowly turning-over plasma pools. The latter is predominantly measured with radioiodinated apoA-I tracers. The data can be analyzed by postulating either separate input pathways to each of the pools or by assuming the fast pool is the precursor to the slow pool. Thus, apoA-I could be initially secreted as a family of particles that are rapidly cleared from plasma, and a portion of this apoprotein then reappears in a slowly turning-over pool that constitutes the major mass of apoA-I. The physiologic identity of these kinetically distinct apoA-I species is unknown; however, the fast pool of apoA-I demonstrated in these studies is strikingly similar to that seen in subjects with Tangier disease who lack the slow pool. The kinetics of apolipoproteins A-I and A-II were examined in human subjects using leucine tracers administered intravenously. High density lipoproteins were separated and apoA-I and A-II were isolated. The specific activity or enrichment data for these apolipoprotein were analyzed by mathematical compartmental modeling. In 11 of 14 subjects studied with a bolus-injected [3H]leucine tracer, in 3 subjects studied similarly with [3H]leucine, and in one subject studied by primed dose, constant infusion of [3H]leucine, a rapidly turning-over apoA-I fraction was resolved. A similar component was observed in 7 of 10 studies of apoA-II. The apoA-I data were analyzed using a compartmental model (Zech, L.A. et al. 1983. J. Lipid Res. 24: 60-71) modified to incorporate plasma leucine as a precursor for apoprotein synthesis. The data permitted resolution of two apoA-I pools, one, C(2), turned-over with a residence time of less than 1 day, the other, C(1), a slowly turning-over pool, appeared in plasma after a delay of less than half a day. C(1) comprised the predominant mass of apoA-I and was also the primary determinant of the residence time of apoA-I. Although the mass of the fast pool, C(2), was considerably less than that of C(1), because of its rapid turnover, the quantities of apoA-I transported through this fast pathway were 2- to 4-fold greater. These kinetic studies indicate that apoA-I is secreted into both fast and slowly turning-over plasma pools. The latter is predominantly measured with radioiodinated apoA-I tracers. The data can be analyzed by postulating either separate input pathways to each of the pools or by assuming the fast pool is the precursor to the slow pool. Thus, apoA-I could be initially secreted as a family of particles that are rapidly cleared from plasma, and a portion of this apoprotein then reappears in a slowly turning-over pool that constitutes the major mass of apoA-I. The physiologic identity of these kinetically distinct apoA-I species is unknown; however, the fast pool of apoA-I demonstrated in these studies is strikingly similar to that seen in subjects with Tangier disease who lack the slow pool. |
Author | Kilgore, L L Stacpoole, P W Diffenderfer, M R Sumner, A E Venkatakrishnan, V Fisher, W R Hall, C M Zech, L A Friday, K E Marsh, J B |
Author_xml | – sequence: 1 givenname: W R surname: Fisher fullname: Fisher, W R – sequence: 2 givenname: V surname: Venkatakrishnan fullname: Venkatakrishnan, V – sequence: 3 givenname: L A surname: Zech fullname: Zech, L A – sequence: 4 givenname: C M surname: Hall fullname: Hall, C M – sequence: 5 givenname: L L surname: Kilgore fullname: Kilgore, L L – sequence: 6 givenname: P W surname: Stacpoole fullname: Stacpoole, P W – sequence: 7 givenname: M R surname: Diffenderfer fullname: Diffenderfer, M R – sequence: 8 givenname: K E surname: Friday fullname: Friday, K E – sequence: 9 givenname: A E surname: Sumner fullname: Sumner, A E – sequence: 10 givenname: J B surname: Marsh fullname: Marsh, J B |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7595084$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUU1v1DAQ9aGotIWfUMknBIdQx47jWJyqio9VK3EArlgTe8y6ysbB9lLtv8fdXe2BC6cZzbz3Rm_eJTmb44yEXLfsfcva_uYbY5w3nCv5lrN3QqtONfqMXJzGL8llzo-MtV3Xt-fkXEkt2dBdkJ_3YcYSLMU_weFskfqY6BjLmgL1kAuF2dU2T_GJZrQJS0w7ukBZP8FuD4YlTmGJS4oFw0xvmxWtZb3dwJxfkRcepoyvj_WK_Pj08fvdl-bh6-fV3e1DY7tOlEYrxqRXvWXg5YDCVVfSc6-1xd4JYYcRVCs7z7VjwguEcWwd55WgxaCtuCKrg66L8GiWFDaQdiZCMPtBTL8MpGpzQqPHru8VG6UA3mnnRjb2ymnXogeGCFXrzUGrOvq9xVzMJmSL0wQzxm02Skk-aDVU4PURuB036E5nj8-te3nY2xRzTuhPiJaZ59zMPjfzHJDhzOxzM7ryPvzDs6FACXEuCcL0H_ZfjeefXg |
CitedBy_id | crossref_primary_10_1016_S0022_2275_20_37626_4 crossref_primary_10_1007_s11745_012_3703_0 crossref_primary_10_1016_S0021_9150_99_00473_6 crossref_primary_10_1016_S0021_9150_01_00690_6 crossref_primary_10_1007_s11745_003_1053_5 crossref_primary_10_1016_S0009_8981_97_00155_1 crossref_primary_10_1177_000456329903600420 crossref_primary_10_1097_00041433_200006000_00006 crossref_primary_10_1194_jlr_R600017_JLR200 crossref_primary_10_1111_j_1365_2362_2004_01322_x crossref_primary_10_1016_S0022_2275_20_30279_0 crossref_primary_10_1016_S0026_0495_97_90262_6 crossref_primary_10_1371_journal_pcbi_1003579 crossref_primary_10_1042_CS20040108 crossref_primary_10_1097_00041433_200302000_00011 crossref_primary_10_1161_ATVBAHA_113_302019 crossref_primary_10_1038_sj_ijo_0802070 crossref_primary_10_1093_ajcn_74_3_308 crossref_primary_10_1161_01_ATV_17_7_1369 crossref_primary_10_1161_01_ATV_16_9_1203 crossref_primary_10_1021_bi9919504 |
Cites_doi | 10.1016/S0022-2275(20)34388-1 10.1172/JCI113266 10.1172/JCI108963 10.1172/JCI114507 10.1016/S0022-2275(20)38300-0 10.1073/pnas.82.18.6305 10.1172/JCI114149 10.1016/S0022-2275(20)38334-6 10.1016/S0022-2275(20)41639-6 10.1006/bbrc.1994.1484 10.1210/jcem-65-3-512 10.1016/S0022-2275(20)42353-3 10.1016/S0022-2275(20)34803-3 10.1016/S0022-2275(20)38301-2 10.1111/j.1432-1033.1988.tb14022.x 10.1172/JCI108513 10.1016/0026-0495(88)90077-7 10.1016/S0022-2275(20)39807-2 10.1161/01.ATV.10.4.582 10.1016/S0022-2275(20)40547-4 10.1172/JCI114405 10.1016/S0021-9258(18)42195-3 10.1016/S0022-2275(20)35361-X 10.1172/JCI116231 10.1016/S0022-2275(20)38492-3 10.1016/S0022-2275(20)38087-1 10.1016/S0022-2275(20)38025-1 10.1016/0003-2697(85)90335-5 10.1007/BF02533471 10.1016/S0022-2275(20)41637-2 10.1016/S0022-2275(20)35195-6 10.1016/0925-4439(93)90149-U |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.1016/S0022-2275(20)39747-9 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EndPage | 1628 |
ExternalDocumentID | oai_doaj_org_article_9b46670b53a249ddb0b67d9d1efa0eea 7595084 10_1016_S0022_2275_20_39747_9 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: HL-29394 – fundername: NCRR NIH HHS grantid: M01RR00082 – fundername: NHLBI NIH HHS grantid: HL-27807 |
GroupedDBID | --- -~X .55 .GJ 0R~ 0VX 18M 29K 2WC 34G 39C 4.4 53G 5GY 5RE 5VS AAEDW AAFWJ AALRI AAXUO AAYOK AAYWO AAYXX ABCQX ABOCM ACCCW ACGFO ACKIV ACNCT ACPRK ACVFH ADBBV ADCNI ADVLN AENEX AEUPX AEXQZ AFFNX AFOSN AFPKN AFPUW AI. AIGII AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BTFSW C1A CITATION CS3 D-I DIK DU5 E3Z EBS EJD F5P FDB FRP GROUPED_DOAJ GX1 H13 HH5 HYE H~9 J5H KQ8 L7B MVM OK1 P2P RHI ROL RPM TBC TR2 TWZ VH1 W8F WH7 WOQ X7M YHG YKV ZGI ZXP ~KM CGR CUY CVF ECM EIF NPM RHF 7X8 |
ID | FETCH-LOGICAL-c443t-97005f76c0af58e3d1015f2f99ce6d33c8ba7154f29d03f3eabb1d226c09389c3 |
IEDL.DBID | DOA |
ISSN | 0022-2275 |
IngestDate | Wed Aug 27 01:33:36 EDT 2025 Thu Jul 10 22:13:45 EDT 2025 Thu Jan 02 22:56:54 EST 2025 Tue Jul 01 01:31:30 EDT 2025 Thu Apr 24 23:11:57 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | http://creativecommons.org/licenses/by/4.0 https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c443t-97005f76c0af58e3d1015f2f99ce6d33c8ba7154f29d03f3eabb1d226c09389c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/9b46670b53a249ddb0b67d9d1efa0eea |
PMID | 7595084 |
PQID | 77528978 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9b46670b53a249ddb0b67d9d1efa0eea proquest_miscellaneous_77528978 pubmed_primary_7595084 crossref_primary_10_1016_S0022_2275_20_39747_9 crossref_citationtrail_10_1016_S0022_2275_20_39747_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1995-07-01 |
PublicationDateYYYYMMDD | 1995-07-01 |
PublicationDate_xml | – month: 07 year: 1995 text: 1995-07-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of lipid research |
PublicationTitleAlternate | J Lipid Res |
PublicationYear | 1995 |
Publisher | Elsevier |
Publisher_xml | – name: Elsevier |
References | Ginsberg (10.1016/S0022-2275(20)39747-9_bib20) 1990; 19 Makrides (10.1016/S0022-2275(20)39747-9_bib32) 1988; 173 Bujanovski (10.1016/S0022-2275(20)39747-9_bib34) 1987; 80 Zech (10.1016/S0022-2275(20)39747-9_bib3) 1983; 24 Brinton (10.1016/S0022-2275(20)39747-9_bib7) 1989; 85 Fisher (10.1016/S0022-2275(20)39747-9_bib13) 1991; 32 Morrison (10.1016/S0022-2275(20)39747-9_bib28) 1992; 267 Cryer (10.1016/S0022-2275(20)39747-9_bib18) 1986; 27 Bojanovski (10.1016/S0022-2275(20)39747-9_bib21) 1985; 26 Cheung (10.1016/S0022-2275(20)39747-9_bib33) 1993; 91 Cohn (10.1016/S0022-2275(20)39747-9_bib10) 1990; 85 Ohta (10.1016/S0022-2275(20)39747-9_bib2) 1988; 29 Green (10.1016/S0022-2275(20)39747-9_bib27) 1978; 61 Schaefer (10.1016/S0022-2275(20)39747-9_bib4) 1982; 23 Hamilton (10.1016/S0022-2275(20)39747-9_bib26) 1976; 58 Golay (10.1016/S0022-2275(20)39747-9_bib9) 1987; 65 Kambouris (10.1016/S0022-2275(20)39747-9_bib29) 1990; 10 Cheung (10.1016/S0022-2275(20)39747-9_bib1) 1984; 259 Le (10.1016/S0022-2275(20)39747-9_bib5) 1988; 37 Maguire (10.1016/S0022-2275(20)39747-9_bib17) 1989; 30 Winkler (10.1016/S0022-2275(20)39747-9_bib24) 1989; 30 Hokland (10.1016/S0022-2275(20)39747-9_bib30) 1992; 33 Brinton (10.1016/S0022-2275(20)39747-9_bib6) 1989; 84 Fisher (10.1016/S0022-2275(20)39747-9_bib16) 1980; 21 10.1016/S0022-2275(20)39747-9_bib31 Ikewaki (10.1016/S0022-2275(20)39747-9_bib12) 1993; 34 10.1016/S0022-2275(20)39747-9_bib19 Schmitz (10.1016/S0022-2275(20)39747-9_bib36) 1985; 82 Schaefer (10.1016/S0022-2275(20)39747-9_bib23) 1979; 14 Kilgore (10.1016/S0022-2275(20)39747-9_bib15) 1985; 145 Rader (10.1016/S0022-2275(20)39747-9_bib8) 1991; 32 Chung (10.1016/S0022-2275(20)39747-9_bib14) 1980; 21 Duchateau (10.1016/S0022-2275(20)39747-9_bib35) 1993; 1182 Lichtenstein (10.1016/S0022-2275(20)39747-9_bib11) 1990; 31 Sadu (10.1016/S0022-2275(20)39747-9_bib22) 1994; 200 Winkler (10.1016/S0022-2275(20)39747-9_bib25) 1989; 30 |
References_xml | – volume: 26 start-page: 185 year: 1985 ident: 10.1016/S0022-2275(20)39747-9_bib21 article-title: Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)34388-1 – volume: 259 start-page: 12201 year: 1984 ident: 10.1016/S0022-2275(20)39747-9_bib1 article-title: Characterization of lipoprotein particles isolated by immunoaffinitychromatography publication-title: Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. – volume: 80 start-page: 1742 year: 1987 ident: 10.1016/S0022-2275(20)39747-9_bib34 article-title: In vivo metabolism of proapolipoprotein A-I in Tangier disease publication-title: J. Clin. Invest. doi: 10.1172/JCI113266 – volume: 61 start-page: 528 year: 1978 ident: 10.1016/S0022-2275(20)39747-9_bib27 article-title: Rat intestine secretes discoidal high density lipoprotein publication-title: J. Clin. Invest. doi: 10.1172/JCI108963 – volume: 85 start-page: 804 year: 1990 ident: 10.1016/S0022-2275(20)39747-9_bib10 article-title: Measurement of very low density and low density lipoprotein apolipoprotein (apo)B-100 and high density lipoprotein apoA-I production in human subjects using deuterated leucine: effect of fasting and feeding publication-title: J. Clin. Invest. doi: 10.1172/JCI114507 – volume: 30 start-page: 979 year: 1989 ident: 10.1016/S0022-2275(20)39747-9_bib24 article-title: Characterization of nascent high density lipoprotein subfractions from perfusates of rat liver publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)38300-0 – volume: 82 start-page: 6305 year: 1985 ident: 10.1016/S0022-2275(20)39747-9_bib36 article-title: Tangier disease: a disorder of intracellular membrane traffic publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.82.18.6305 – volume: 84 start-page: 262 year: 1989 ident: 10.1016/S0022-2275(20)39747-9_bib6 article-title: Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women publication-title: J. Clin. Invest. doi: 10.1172/JCI114149 – volume: 30 start-page: 757 year: 1989 ident: 10.1016/S0022-2275(20)39747-9_bib17 article-title: Sodium dodecyl sulfate-glycerol polyacrylamide slab gel electrophoresis for the resolution of apolipoproteins publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)38334-6 – volume: 32 start-page: 1849 year: 1991 ident: 10.1016/S0022-2275(20)39747-9_bib8 article-title: In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I andLpA-I, A-II publication-title: J. Lipid Res doi: 10.1016/S0022-2275(20)41639-6 – volume: 200 start-page: 557 year: 1994 ident: 10.1016/S0022-2275(20)39747-9_bib22 article-title: Plasma HDL levels are regulated by the catabolic rate of large particles of lipoprotein containing apoA-I publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1994.1484 – volume: 65 start-page: 512 year: 1987 ident: 10.1016/S0022-2275(20)39747-9_bib9 article-title: High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL publication-title: j. Clin. Endocrinol. Melab. doi: 10.1210/jcem-65-3-512 – volume: 31 start-page: 1693 year: 1990 ident: 10.1016/S0022-2275(20)39747-9_bib11 article-title: Comparison of deuterated leucine, valine, and lysine in the measurementFisher et al. Secretory pathways for apoA-I in humans 1627of human apolipoprotein A-I and B-100 kinetics publication-title: J. Lipid Res doi: 10.1016/S0022-2275(20)42353-3 – volume: 21 start-page: 760 year: 1980 ident: 10.1016/S0022-2275(20)39747-9_bib16 article-title: The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)34803-3 – volume: 30 start-page: 989 year: 1989 ident: 10.1016/S0022-2275(20)39747-9_bib25 article-title: Metabolism of triglyceride-rich nascent rat hepatic high density lipoproteins publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)38301-2 – ident: 10.1016/S0022-2275(20)39747-9_bib19 – volume: 173 start-page: 465 year: 1988 ident: 10.1016/S0022-2275(20)39747-9_bib32 article-title: Sequence and expression of Tangier apoA-I gene publication-title: Eur.J. Biochem. doi: 10.1111/j.1432-1033.1988.tb14022.x – volume: 58 start-page: 667 year: 1976 ident: 10.1016/S0022-2275(20)39747-9_bib26 article-title: Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver publication-title: J. Clin. Invest. doi: 10.1172/JCI108513 – volume: 37 start-page: 614 year: 1988 ident: 10.1016/S0022-2275(20)39747-9_bib5 article-title: Heterogeneity of apolipoprotein A-I turnover in subjects with reducedconcentrations of plasma high density lipoprotein cholesterol. publication-title: Metabolism. doi: 10.1016/0026-0495(88)90077-7 – volume: 21 start-page: 284 year: 1980 ident: 10.1016/S0022-2275(20)39747-9_bib14 article-title: Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifueation in a vertical rotor publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)39807-2 – volume: 10 start-page: 582 year: 1990 ident: 10.1016/S0022-2275(20)39747-9_bib29 article-title: Retroendocytosis of high density lipoproteins by the human hepatoma cell line, HepG2 publication-title: Arteriosclerosis. doi: 10.1161/01.ATV.10.4.582 – volume: 33 start-page: 1335 year: 1992 ident: 10.1016/S0022-2275(20)39747-9_bib30 article-title: Cellular localization and characterization of proteins that bind high density lipoprotein publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)40547-4 – volume: 85 start-page: 144 year: 1989 ident: 10.1016/S0022-2275(20)39747-9_bib7 article-title: A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates publication-title: Clin. Invest. doi: 10.1172/JCI114405 – volume: 267 start-page: 13205 year: 1992 ident: 10.1016/S0022-2275(20)39747-9_bib28 article-title: Evidence for two sites on rat liver plasma membranes which interact with high density lipoprotein publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)42195-3 – volume: 34 start-page: 2207 year: 1993 ident: 10.1016/S0022-2275(20)39747-9_bib12 article-title: Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)35361-X – volume: 91 start-page: 522 year: 1993 ident: 10.1016/S0022-2275(20)39747-9_bib33 article-title: Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux publication-title: J. Clin. Invest. doi: 10.1172/JCI116231 – volume: 29 start-page: 721 year: 1988 ident: 10.1016/S0022-2275(20)39747-9_bib2 article-title: Studies on the lipid and apolipoprotein compositions of two species of apoA-I-containing lipoproteins in nor-molipidemic males and females publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)38492-3 – volume: 19 start-page: 211 year: 1990 ident: 10.1016/S0022-2275(20)39747-9_bib20 article-title: Lipoprotein physiology and its relationship to athero-genesis publication-title: Lipid Disorders. – volume: 23 start-page: 850 year: 1982 ident: 10.1016/S0022-2275(20)39747-9_bib4 article-title: Human apolipoprotein A-I and A-II metabolism publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)38087-1 – volume: 24 start-page: 60 year: 1983 ident: 10.1016/S0022-2275(20)39747-9_bib3 article-title: Metabolism of humanapolipo-proteins A-I and A-II: compartmental models publication-title: J. Lipid. Res. doi: 10.1016/S0022-2275(20)38025-1 – volume: 145 start-page: 113 year: 1985 ident: 10.1016/S0022-2275(20)39747-9_bib15 article-title: The determination of specific radioactivity of proteins eluted intact from polyacrylamide gels, utilizing a fluorescamine assay publication-title: Anal. Biochem. doi: 10.1016/0003-2697(85)90335-5 – volume: 14 start-page: 511 year: 1979 ident: 10.1016/S0022-2275(20)39747-9_bib23 article-title: The composition and metabolism of high density lipoprotein subfractions publication-title: Lipids. doi: 10.1007/BF02533471 – volume: 32 start-page: 1823 year: 1991 ident: 10.1016/S0022-2275(20)39747-9_bib13 article-title: Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)41637-2 – volume: 27 start-page: 508 year: 1986 ident: 10.1016/S0022-2275(20)39747-9_bib18 article-title: Direct measurement of apolipoprotein B synthesis in human very low density lipoprotein using stable isotopes and mass spectrometry publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)35195-6 – ident: 10.1016/S0022-2275(20)39747-9_bib31 – volume: 1182 start-page: 30 year: 1993 ident: 10.1016/S0022-2275(20)39747-9_bib35 article-title: Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I:A-II and LpA-IV particles from plasma publication-title: Biochim. Biophys. Acta. doi: 10.1016/0925-4439(93)90149-U |
SSID | ssj0014461 |
Score | 1.5749345 |
Snippet | The kinetics of apolipoproteins A-I and A-II were examined in human subjects using leucine tracers administered intravenously. High density lipoproteins were... |
SourceID | doaj proquest pubmed crossref |
SourceType | Open Website Aggregation Database Index Database Enrichment Source |
StartPage | 1618 |
SubjectTerms | Apolipoprotein A-I - biosynthesis Apolipoprotein A-I - metabolism Apolipoprotein A-II - biosynthesis Apolipoprotein A-II - metabolism Female Humans Hyperlipoproteinemia Type II - blood Kinetics Leucine - metabolism Middle Aged Tritium |
Title | Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7595084 https://www.proquest.com/docview/77528978 https://doaj.org/article/9b46670b53a249ddb0b67d9d1efa0eea |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9QwGLWqcigXBF3EsBQfUFUOBsdrfBwqqpZROSAqesLyKiGVTEWmqvrv-ewkUzigXnpKYtlK5PdFfp-X9xB6m0Rs2jZ4oqKMBB4oMaENJOjQ8tBmFWOZGjj7ok7OxecLefGX1VfZEzbIAw8d98F4oZSmXnIHmUKMnnqlo4lNyo6mVKkRjHlTMjWuH0CS00w64YxpeXd2p5wNHgsPGX3HC58m5p9RqYr3_59x1pHn-Cl6MlJGPB8-9RnaSN022pl3kC7_usUHuG7irLPj22jraDJw20E_FsAgoQ1Oo3MoBoKKPUCDHc6uX2HXRbjtL5c3uC_0sSy44-JRfONua2VXPByullXM4WeH5-QUw6X6-vW76Pz407ejEzLaKZAgBF8Ro-GPy1oF6rJsEwdcGplZNiYkFTkg450GRpWZiZRnnpz3TQR6FqgBWhP4Htrsll16jjBnbTReOwc1RWLG5abo2DGVJaVRNDMkpu60YdQaL5YXl_ZuUxmgYAsKllFbUbBmht6vm10NYhv3NfhYsFpXLlrZtQAiyI4RZO-LoBl6MyFtAaGyYOK6tLzurdYS8lHdztDeEADrF2lZ3HPFi4d4_0v0eDgnX_YAv0Kbq9_X6TUwnZXfR4_mi6_fF_s1uP8Am5n45A |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kinetic+evidence+for+both+a+fast+and+a+slow+secretory+pathway+for+apolipoprotein+A-I+in+humans&rft.jtitle=Journal+of+lipid+research&rft.au=W+R+Fisher&rft.au=V+Venkatakrishnan&rft.au=L+A+Zech&rft.au=C+M+Hall&rft.date=1995-07-01&rft.pub=Elsevier&rft.issn=0022-2275&rft.volume=36&rft.issue=7&rft.spage=1618&rft.epage=1628&rft_id=info:doi/10.1016%2FS0022-2275%2820%2939747-9&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_9b46670b53a249ddb0b67d9d1efa0eea |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2275&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2275&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2275&client=summon |